# US 2025/0059540 A1 · Double stranded rna targeting angiopoietin-like 3 (angptl-3) and methods of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0059540 A1
- Document ID: US20250059540A1
- Status: Published application
- Kind: A1
- Application number: 18/757,656
- Filed: 2024-06-28
- Published: 2025-02-20
- Earliest claimed: 2021-11-19
- Assignees: Sanegene Bio USA Inc.
- Applicants: Sanegene Bio USA Inc.
- Inventors: Chunyang ZHANG; Shiyu WANG; Xiaochuan CAI; Weimin WANG; Zhongfa YANG
- Web page: https://patentgrep.com/patent/US20250059540A1

## CPC

- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/1136: {against growth factors, growth regulators, cytokines, lymphokines or hormones}
- A61P 3/06: Antihyperlipidemics
- C12N 2310/11: Antisense
- C12N 2310/14: interfering nucleic acids [NA]
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The disclosure relates to isolated oligonucleotides comprising duplex regions targeting angiopoietin-like 3 (ANGPTL-3), and delivery systems, kits and compositions comprising same, and methods of using same for inhibiting or downregulating ANGPTL-3.

## Claims

### Claim 1

An isolated oligonucleotide comprising a sense strand and an anti-sense strand, wherein:
the sense strand comprises a nucleotide sequence that is substantially identical to a region comprising 19-25 nucleotides between any one of the nucleotide positions selected from:
a) 52 to 93;
b) 133 to 184;
c) 246 to 304;
d) 337 to 414;
e) 433 to 503;
f) 522 to 571;
g) 617 to 700;
h) 717 to 737;
i) 836 to 905;
j) 944 to 964;
k) 1013 to 1093;
l) 1353 to 1386; and
m) 1407 to 1427,
from the 5′ end of an Angiopoietin-like protein 3 (ANGPTL-3) mRNA sequence according to SEQ ID NO: 1,
and the anti-sense strand is substantially complementary to the sense strand such that the sense strand and the anti-sense strand together form a double stranded region.

### Claim at position 2

-51. (canceled)
